Impact Factor
2.49
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.44
119 total citations
h5-index
13
h5 depth signal
Cited share
45.2%
38 of 84
Total citations
119
Citation footprint
Metric signal
1.22
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
150
India
69
Italy
38
China
21
Turkey
12
Citing Fields of Research
Oncology
94
Cancer & Development
74
Immunology
58
Cancer, Autophagy & Apoptosis
41
Liver & Colon Cancer
32
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
743
Articles tracked across the journal lifetime
Indexed publication set
84
38 cited publications
Last 12 months
27
27.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
United States
150 citing publications
Leading citing field
Oncology
94 citing publications
Latest tracked publication
1 January 2026
10 recent records available
Coverage & Indexing History
v1n1, 1989-
v1n1, 1989-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Cancer & Development
Inflammatory Bowel Diseases & Infections
Cancer, Autophagy & Apoptosis
Protein Structure & Folding
Breast Cancer
Broad Categories
Neoplasms
Immunology
Inflammatory Bowel Diseases & Infections
Breast Cancer
Protein Structure & Folding
Oncology
Lung Cancer
MeSH Descriptors
Neoplasms
Oncogenes
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1615/critrevoncog.2026068412
Open DOI
Preface T Regulatory Cells as Architects of the Tumor Microenvironment
02
03
DOI 10.1615/critrevoncog.2026066749
Open DOI
Bisphenols Exposure Mediated Modulation of Molecular, Metabolic, and Immunological Pathways in Colorectal Cancer: A Comprehensive Overview
04
DOI 10.1615/critrevoncog.2026067041
Open DOI
Precision medicine for breast cancer based on urinary and serum levels of plastic pollutants in Mexican patients
05
DOI 10.1615/critrevoncog.2026066109
Open DOI
mRNA CARs: an emerging new-old idea
06
DOI 10.1615/critrevoncog.2026066934
Open DOI
Challenges in Targeting Treg Cells for Cancer Therapy: Future Perspectives
07
DOI 10.1615/critrevoncog.2026066638
Open DOI
Regulatory T Cells in Breast Cancer: Impact on Tumor Immune Evasion and Response to Immunotherapy
08
DOI 10.1615/critrevoncog.2026066487
Open DOI
Untapped Potential: Peptide Ligands as Guides for Engineered T Cells
09
DOI 10.1615/critrevoncog.2026066328
Open DOI
Taming the Neuroinflammatory Cost of CAR T Therapy
10
DOI 10.1615/critrevoncog.2026066410
Open DOI
on a personal note
Bibliographical & Catalog Notes
Issues for <2006- > have title: CRO.
Title from cover.
Place of publication varies.
Suspended after v. 11, no. 4 (2000); resumed with v.12, no. 1/2 (July 2006).
Also issued online.
19950523 Not printed on acid-free paper